Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein. [PDF]
Mehrabian M +10 more
europepmc +1 more source
α-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model. [PDF]
So RWL +6 more
europepmc +1 more source
The Role of Cellular Prion Protein in Promoting Stemness and Differentiation in Cancer. [PDF]
Ryskalin L +6 more
europepmc +1 more source
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivo. [PDF]
da Silva Correia A +10 more
europepmc +1 more source
cAMP-induced decrease in cell-surface laminin receptor and cellular prion protein attenuates amyloid-β uptake and amyloid-β-induced neuronal cell death. [PDF]
Gopalakrishna R +8 more
europepmc +1 more source
Therapeutic targeting of cellular prion protein: toward the development of dual mechanism anti-prion compounds. [PDF]
Masone A +4 more
europepmc +1 more source
Expression of the cellular prion protein by mast cells in white-tailed deer carotid body, cervical lymph nodes and ganglia. [PDF]
Kincaid AE +5 more
europepmc +1 more source
Update on a brain-penetrant cardiac glycoside that can lower cellular prion protein levels in human and guinea pig paradigms. [PDF]
Eid S +6 more
europepmc +1 more source
The Cellular Prion Protein: A Promising Therapeutic Target for Cancer. [PDF]
Go G, Lee SH.
europepmc +1 more source
NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. [PDF]
Giachin, G +3 more
core +1 more source

